Home > Dorzagliatin

molecules of the month

<< Back to May

Dorzagliatin

Recent Publication

oral allosteric glucokinase activator

Ph. III candidate in T2DM

HbA1c reduction vs placebo

Nat. Med.

Hua Medicine, Shanghai, CN

Context. Dorzagliatin (Hua Medicine) is an oral dual-acting full glucokinase (GK) activator being developed for type 2 diabetes. More than 50 years since the first report of the role…

this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.

LEARN MORE

Dorzagliatin

this content is exclusive to Premium members

this content is exclusive to
Premium members